News & Updates

Join As Board

Dear Reviewer, You can join our Reviewer team without given any charges in our journal. Submit Details on below link: Join As Board

Submit Article

Dear Authors, Article publish in our journal for Volume-1,Issue-1. For article submission on below link: Submit Manuscript

PHYTOCHEMICAL CHARACTERIZATION AND ASSESSMENT OF THE ANTIDIABETIC POTENTIAL OF COLEUS BARBATUS LEAF EXTRACT

Area: Department of Pharmacology
Abstract: Coleus barbatus (Andr.) Benth. (syn. Plectranthus barbatus), commonly known as Indian coleus or patharchur, is a perennial aromatic herb of the family Lamiaceae whose leaves feature prominently in the traditional medicine of India, East Africa and Brazil for managing diabetes and allied metabolic disorders. The present review consolidates and critically examines past work on the phytochemical screening and antidiabetic evaluation of leaf extracts of C. barbatus, emphasising qualitative phytochemistry, in vitro enzyme inhibition and in vivo hypoglycaemic models. Published reports indicate that leaf extracts consistently contain diterpenoids (with forskolin detectable only in certain chemotypes), phenolics and tannins, flavonoids, alkaloids, saponins, steroids and an essential oil rich in oxygenated monoterpenes. In vitro studies document dose-dependent inhibition of porcine pancreatic α-amylase and yeast α-glucosidase that, for phenolic-rich extracts, approaches the potency of acarbose, although some turbo-extracts with high phenolic content failed to inhibit α-amylase. In vivo studies in alloxan- and streptozotocin-diabetic rodents report fasting-glucose lowering of roughly 19–36%, improved glucose tolerance and restored antioxidant defences, consistent with the known cAMP-mediated insulinotropic action of forskolin. Human data remain limited to root-derived forskolin supplements, which improved insulin resistance in overweight adults. The evidence suggests convergent enzyme-inhibitory, insulinotropic and antioxidant mechanisms, but standardisation of leaf extracts, characterisation of leaf-specific markers and adequately powered clinical trials are required before leaf preparations can be recommended as adjunct antidiabetic therapy. The leaf extract exhibits wide safety margins, with median lethal doses exceeding 10,000 mg/kg in rodents. The review also identifies several methodological gaps that currently preclude formal meta-analysis.
Author: Zeba Roksar¹, Dr. Kailash Kumar Pathak², Firoz Khan3
DOI: MJAP/05/3060
Page: 148-163
Paper Id: 3060
Publication Date: 17-Nov-2026
Download:
© 2024 MJAP. All rights reserved. Developed By Inclusion Web